XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.25.3

Equity | 9 Months Ended
--- | ---
Oct. 31, 2025
Equity [Abstract] |
Equity | 9. Equity Equity Incentive Plans In September 2021, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”) as a successor of the Company’s 2015 Equity Incentive Plan (together the “Plans”). In the event that shares previously issued u nder the above Plans are reacquire d by the Company, such shares shall be added to the number of shares then available for issuance under the 2021 Plan. In the event that an outstanding stock option for any reason expires or is canceled, the shares allocable to the unexercised portion of su ch stock option will be added to the number of shares then available for issuance under the 2021 Plan. Both Plans allow the grantees to early exercise stock options. Stock Options, RSUs and PSUs The following table summarizes options activity under the Plans, and related information:
| Number of Stock Options Outstanding (in thousands) |  | Weighted Average Exercise Price |  | Weighted Average Remaining Years |  | Aggregate Intrinsic value (in millions)
Balances at January 31, 2025 | 5,896 |  |  | $ | 14.27 |  |  | 5.41 |  | $ | 344.8 |
Options exercised | (1,235) |  |  | 12.53 |  |  |  |  |
Options canceled | (15) |  |  | 11.83 |  |  |  |  |
Options forfeited | (26) |  |  | 18.45 |  |  |  |  |
Balances at October 31, 2025 | 4,620 |  |  | $ | 14.72 |  |  | 4.12 |  | $ | 157.2 |
Options vested at October 31, 2025 | 4,440 |  |  | $ | 14.60 |  |  | 4.06 |  | $ | 151.6 |
Options vested and expected to vest at October 31, 2025 | 4,620 |  |  | $ | 14.72 |  |  | 4.12 |  | $ | 157.2 |
During the three and nine months ended October 31, 2025, the Company recorded $3.9 million and $13.2 million of stock-based compensation expense related to options, respectively. During the three and nine months ended October 31, 2024, the Company recorded $3.1 million and $10.0 million of stock-based compensation expense related to options, respectively. As of October 31, 2025, approx imately $8.2 million of total unrecognized stock-based compensation relates to the modification of stock options previously granted to the Company’s former CEO. Total unrecognized stock-based compensation cost related to stock options is expected to be recognized over a weighted-average period of 0.5 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. The following table summarizes the Company’s RSU activity:
| Number of Shares (in thousands) |  | Weighted- Average grant date fair value
Balances at January 31, 2025 | 8,259 |  |  | $ | 50.64 |
Granted | 5,472 |  |  | 45.24 |
Vested | (2,701) |  |  | 49.41 |
Canceled/forfeited | (2,168) |  |  | 47.99 |
Balances at October 31, 2025 | 8,862 |  |  | $ | 48.32 |
These RSUs are grants of shares of the Company’s Class A common stock, the vesting of which is based on the requisite service requirement. Generally, the Company’s RSUs are subject to forfeiture and are expected to vest over two to four years ratably on a combination of bi-annual and quarterly basis. During the three and nine months ended October 31, 2025, the Company recorded $44.4 million and $136.4 million of stock-based compensation expense related to RSUs, respectively. During the three and nine months ended October 31, 2024, the Company recorded $40.3 million and $117.1 million of stock-based compensation expense related to RSUs, respectively. As of October 31, 2025, approximately $399.2 million of total unrecognized compensation cost was related to RSUs granted to team members that is expected to be recognized over a weighted-average period of 2.8 years. The expected stock compensation expense remaining to be recognized reflects only outstanding stock awards as of the periods presented, and assumes no forfeitures. PSUs During the nine months ended October 31, 2025, the Company granted 0.3 million PSUs to senior members of its management team subject to the achievement of specified performance targets and continuous service through the applicable vesting dates. U nder the terms of the awards, the recipient may earn between 0% and 200% of the original grant. The performance condition s are set to be achieved in fiscal year 2026 through fiscal year 2028 and the service condition must be met on each vest date. The Company has also granted PSUs to executive officers in prior years. During the three and nine months ended October 31, 2025, the Company recorded a net gain of $0.2 million and a net expense of $1.1 million, respectively related to PSUs. During the three and nine months ended October 31, 2024, the Company recorded total stock-based compensation expense of $0.9 million and $1.8 million, respectively. As of October 31, 2025, total unrecognized stock-based compensation expense related to PSUs was $3.8 million, which is expected to be recognized over a weighted-average period of 2.5 years. 2021 Employee Stock Purchase Plan (“ESPP”) In September 2021, the Company’s board of directors and its stockholders approved the ESPP and participation of eligible team members. The Company reco rded $3.0 million and $9.7 million of stock-based compensation expense related to the ESPP during the three and nine months ended October 31, 2025, respectively. The Company rec orded $2.5 million and $8.6 million of stock-based compensation expense related to the ESPP during the three and nine months ended October 31, 2024, respectively. As of October 31, 2025, approximately $16.5 million of total unrecognized compensation cost was related to the ESPP that is expected to be recognized over 1.6 years. Stock-Based Compensation Expense The Company recognized stock-based compensation expense as follows (in thousands):
| Three Months Ended October 31, |  | Nine Months Ended October 31,
| 2025 |  | 2024 |  | 2025 |  | 2024 |  |
Cost of revenue | $ | 2,300 |  |  | $ | 1,993 |  |  | $ | 6,490 |  |  | $ | 5,924 |  |  |
Sales and marketing | 17,354 |  |  | 17,012 |  |  | 59,395 |  |  | 54,290 |  |  |
Research and development | 15,560 |  |  | 14,384 |  |  | 49,029 |  |  | 42,834 |  |  |
General and administrative | 16,468 |  |  | 14,653 |  |  | 46,879 |  |  | 36,215 |  |  |
Stock-based compensation expense, net of amounts capitalized | 51,682 |  |  | 48,042 |  |  | 161,793 |  |  | 139,263 |  |  |
Capitalized stock-based compensation | 367 |  |  | — |  |  | 367 |  |  | — |  |  |
Total stock-based compensation expense (1) | $ | 52,049 |  |  | $ | 48,042 |  |  | $ | 162,160 |  |  | $ | 139,263 |  |  |
(1) The table above includes stock-based compensation of JiHu. Refer to “Note 10. Joint Venture” for further discussion. The corporate income tax benefit recognized in the condensed consolidated statements of operations for stock-based compensation expense was zero for each of the three and nine months ended October 31, 2025 and 2024, respectively. Charitable Donation of Common Stock In September 2021, the C ompany’s board of directors approved the reservation of up to 1,635,545 shares of Class A common stock for issuance to charitable organizations. In March 2025 and 2024, the Company’s board of directors approved annual donations of 163,555 and 221,195 shares of Class A common stock, respectively, to the GitLab Foundation (the “Foundation”), a California nonprofit public benefit corporation. The Foundation is also a related party as certain of the Company’s officers serve as directors of the Foundation. These donations shall occur in four equal quarterly distributions. During the three and nine months ended October 31, 2025, the Company donated 40,889 shares and 122,667 shares of Class A common stock at fair value to the Foundation, respectively. During the three and nine months ended October 31, 2024, the Company donated 52,940 shares and 173,181 shares of Class A common stock at fair value to the Foundation, respectively. The fair value of the common stock was determined based on the quoted market price on the grant date. The donation expense of $2.0 million and $5.5 million was recorded in general and administrative expense in the condensed consolidated statements of operations for the three and nine months ended October 31, 2025, respectively. The donation expense of $3.0 million and $8.9 million was recorded in general and administrative expense in the condensed consolidated statements of operations for the three and nine months ended October 31, 2024, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration